Early Vitrectomy vs Laser for Early Diabetic Eye Disease
Part of Eyes & vision clinical trials.
This trial compares two treatments for early diabetic retinopathy—a condition where high blood sugar damages blood vessels in the eye. Researchers want to see if removing fluid from inside the eye (vitrectomy) works better than laser treatment to prevent vision loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- You have early proliferative diabetic retinopathy (new abnormal blood vessels in the eye) with some bleeding that doesn't block vision
- Your eye is clear enough for laser treatment and imaging
- You have not had previous eye laser or surgery for this condition
- Your blood sugar and blood pressure are reasonably controlled
- You can commit to multiple follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches to treat advanced diabetic eye disease (proliferative diabetic retinopathy): injections of faricimab plus laser, versus surgery (vitrectomy) with laser. It is for people with diabetes who need treatment for PDR and still have relatively good vision (20/100 or better) in the affected eye.
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
This study looks at how people with severe nonproliferative diabetic retinopathy do after they have vitrectomy (a type of eye surgery). The goal is to better predict prognosis and possibly improve care planning after surgery.
This trial compares a minimally invasive eye procedure (vitrectomy with peeling) versus anti-VEGF injections to treat new diabetic macular edema in people who have not had treatment yet. It looks at which option improves vision and eye swelling for people with diabetes.
This trial tests a different pattern of laser treatment for people with diabetic eye disease (proliferative diabetic retinopathy) that has started growing abnormal blood vessels. The goal is to see if this pattern works well or better than the standard approach.
This trial tests if a targeted laser treatment guided by a special eye scan can slow the progression of blocked blood vessels in the retina for people with diabetes-related eye disease. It may help preserve vision by treating damaged areas before they worsen.
Hear when a new Proliferative Diabetic Retinopathy (PDR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.